BFNHOTCLaboratory Analytical InstrumentsFiscal year ends December 31
BIOFORCE NANOSCIENCES HOLDINGS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$6.87−0.04 (-0.58%)
Close on Oct 19, 2026
- Market cap
- $230.52M
- P/E (TTM)
- 687.2
- Dividend yield
- –
Bioforce Nanosciences statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Laboratory Analytical Instruments companies for comparison
Valuation
| Measure | Bioforce Nanosciences | Industry median |
|---|---|---|
| Market Cap | $230.55M | $230.55M |
| Enterprise Value | $230.55M | $202.97M |
| PE Ratio | 687.20 | 31.60 |
| PB Ratio | 100.09 | 3.04 |
| P/TBV Ratio | 100.09 | 4.43 |
Income (trailing twelve months)
| Measure | Bioforce Nanosciences | Industry median |
|---|---|---|
| Net Income | -$98.25K | -$6.57M |
| EPS (Diluted) | $0.01 | -$0.08 |
Returns
| Measure | Bioforce Nanosciences | Industry median |
|---|---|---|
| Return on Equity (ROE) | -10.2% | -18.2% |
| Return on Assets (ROA) | -8.23% | -13.3% |
Balance sheet
| Measure | Bioforce Nanosciences | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $307 | $36.66M |
| Net Cash (Debt) | $307 | $3.92M |
| Net Cash Per Share | $0.00 | $0.28 |
| Equity (Book Value) | $2.30M | $55.33M |
| Book Value Per Share | $0.07 | $2.87 |
| Tangible Book Value | $2.30M | $10.79M |
| Working Capital | $2.07M | $56.72M |
Financial position
| Measure | Bioforce Nanosciences | Industry median |
|---|---|---|
| Current Ratio | 25.41 | 2.48 |
| Quick Ratio | 0.00 | 1.53 |
Cash flow (trailing twelve months)
| Measure | Bioforce Nanosciences | Industry median |
|---|---|---|
| Operating Cash Flow | -$41.93K | -$566.22K |
Efficiency
| Measure | Bioforce Nanosciences | Industry median |
|---|---|---|
| Profits Per Employee | -$32.75K | -$51.88K |
| Employee Count | 3 | 185 |
Dividends and yields
| Measure | Bioforce Nanosciences | Industry median |
|---|---|---|
| Earnings Yield | -0.04% | -6.88% |
Shares
| Measure | Bioforce Nanosciences | Industry median |
|---|---|---|
| Shares Outstanding | 33,549,000 | 44,302,700 |
| Shares Change (YoY) | 7.88% | 3.36% |
| Shares Change (QoQ) | 0.08% | 0.27% |
Scores
| Measure | Bioforce Nanosciences | Industry median |
|---|---|---|
| Graham Number | $0.12 | $35.97 |
| Graham Upside | -98.2% | -57.0% |
| Altman Z-Score | 1537.78 | 1.95 |
| Piotroski F-Score | 3 | 5 |
Calculated by StockData from Bioforce Nanosciences's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.